Eagle Pharmaceuticals Inc (EGRX) Inventory Turnover Ratio, from second quarter 2023 to second quarter 2022, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Eagle Pharmaceuticals inc   (NASDAQ: EGRX)
 

Eagle Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Eagle Pharmaceuticals Inc inventory turnover ratio, the Eagle Pharmaceuticals Inc 's ability to sell and replace its inventory in the second quarter 2023, sequentially increased to 1.48 in the second quarter 2023, yet the ratio remained below the average, as EGRX's market remain challenging.Average inventory processing period, for the Eagle Pharmaceuticals Inc in Jun 30 2023 quarter, has decreased to 247 days, compare to 252 days, in the Mar 31 2023 quarter.

Within Healthcare sector 296 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2023, to 995, from total ranking in the first quarter 2023 at 1748.

EGRX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Eagle Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

EGRX Inventory Turnover Ratio (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Y / Y Inventory Growth -26.39 % 77.85 % 118.16 % 585.51 % 595.83 %
Y / Y Cost of Sales Growth -20.37 % -31.28 % 88.2 % 280.4 % 167.75 %
Inventory Turnover Ratio (TTM) 1.48 1.45 1.76 1.83 2.16
EGRX's Total Ranking # 995 # 1748 # 1664 # 1550 # 1667
Average inventory processing period 247 251 207 200 169
Seq. Inventory Growth -3.76 % -7.65 % -25.15 % 10.64 % 132.54 %
Seq. Cost of Sales Growth -2.55 % -5.16 % -12.59 % -1.43 % -15.91 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 89
Healthcare Sector # 297
Overall Market # 995

Inventory Turnover Ratio Statistics
High Average Low
5.65 3.83 1.45
(Dec 31 2017)   (Mar 31 2023)



EGRX Company Profile >> Back to EGRX Efficiency Comparisons >> Compare EGRX Inventory Turnover Ratio to its Competitors

Financial Statements
Eagle Pharmaceuticals Inc 's Inventories $ 42 Millions Visit EGRX's Balance sheet
Eagle Pharmaceuticals Inc 's Cost of Revenues TTM $ 73 Millions Visit EGRX's Income Statement
What are EGRX's Sales? Visit EGRX's Sales by Segment

Other Inventory Turnover Ratios
Eagle Pharmaceuticals Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
EGRX's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for EGRX's Competitors
Inventory Turnover Ratio for EGRX's Suppliers
Inventory Turnover Ratio for EGRX's Customers

You may also want to know
EGRX's Sales Growth Rates EGRX's Pe Price to earnings ratio EGRX's Receivables Turnover Ratio EGRX's Stock Quote
EGRX's Net Income Growth Rates EGRX's Ps Price to Sales ratio EGRX's Sales per Employee EGRX's Asset Turnover Ratio
EGRX's Net Margin EGRX's Pb Price to Book ratio EGRX's Financial Strength Ratios EGRX's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2023, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2023 Inventories at quarter ending Jun 30 2023
Adm Tronics Unlimited Inc   4.72 $ 1.918  Millions$ 0  Millions
Precision Optics Corporation Inc   4.70 $ 13.310  Millions$ 3  Millions
Henry Schein Inc   4.64 $ 8,744.000  Millions$ 1,886  Millions
Lifemd Inc   4.44 $ 16.068  Millions$ 4  Millions
Bristol myers Squibb Company  4.43 $ 10,388.000  Millions$ 2,346  Millions
Integrated Biopharma Inc  4.37 $ 46.000  Millions$ 11  Millions
Neptune Wellness Solutions Inc   4.34 $ 39.944  Millions$ 9  Millions
Warby Parker Inc   4.28 $ 282.378  Millions$ 66  Millions
Organogenesis Holdings Inc   4.24 $ 106.453  Millions$ 25  Millions
Harrow Inc   4.23 $ 31.157  Millions$ 7  Millions
Catalent Inc   4.20 $ 3,223.000  Millions$ 768  Millions
T2 Biosystems Inc   4.20 $ 18.679  Millions$ 4  Millions
Escalon Medical Corp   4.12 $ 6.673  Millions$ 2  Millions
West Pharmaceutical Services Inc   4.11 $ 1,773.200  Millions$ 431  Millions
Steris Plc  4.10 $ 2,870.535  Millions$ 701  Millions
Teva Pharmaceutical Industries Limited  4.08 $ 8,200.000  Millions$ 2,009  Millions
Moderna Inc   4.06 $ 4,541.000  Millions$ 1,118  Millions
Novocure Limited  4.04 $ 122.269  Millions$ 30  Millions
Urogen Pharma Ltd   4.03 $ 8.991  Millions$ 2  Millions
Adaptive Biotechnologies Corporation  3.86 $ 68.087  Millions$ 18  Millions
Vericel Corporation  3.76 $ 58.241  Millions$ 15  Millions
Idexx Laboratories Inc  3.74 $ 1,409.005  Millions$ 377  Millions
Twist Bioscience Corporation  3.73 $ 144.542  Millions$ 39  Millions
Envista Holdings Corporation  3.71 $ 1,109.300  Millions$ 299  Millions
Gilead Sciences Inc   3.65 $ 5,634.000  Millions$ 1,545  Millions
Endo International Plc  3.64 $ 1,022.092  Millions$ 281  Millions
Caredx Inc   3.62 $ 67.048  Millions$ 19  Millions
Cadre Holdings inc   3.60 $ 278.061  Millions$ 77  Millions
Tactile Systems Technology Inc   3.59 $ 77.649  Millions$ 22  Millions
Orasure Technologies Inc  3.59 $ 291.908  Millions$ 81  Millions

Date modified: 2026-09-08T15:11:01+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.